$SLN
Silence Therapeutics plc
Nasdaq · Healthcare · Pharmaceutical Preparations · London
SLN chart
What traders are saying about $SLN
Latest postsSilence Therapeutics plc news
- Discontinued operations of Silence Therapeutics PLC Sponsored ADR – HAM:XRP2
TradingView ·
- Weekly Recap: Merck KGaA $20/ADS buyout and Divesiran 88% Phase II response
TradingView ·
- Merck to Acquire Silence Therapeutics for $1.3 Billion, Expanding Rare Disease Portfolio with siRNA Innovation
BioPharma APAC ·
- Silence Therapeutics Plc - American Depository Share Estimates – NASDAQ:SLN
TradingView ·
- Silence Therapeutics' Ali Mortazavi: A £5 Million AIM Listing Became a $1.3 Billion Merck KGaA Takeover
BigGo Finance ·
- Silence Therapeutics (NASDAQ:SLN) Stock: Up Sharply in a Month on a Merck KGaA Buyout
kalkine.ca ·
- Penny Stock TEN Holdings (NASDAQ:XHLD) Rebounds as Silence Therapeutics (NASDAQ:SLN) Leads Weekly Reversals
kalkine.ca ·
- Merck to acquire Silence Therapeutics in US$1.3bn deal
Health Tech World ·
- Silence Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Silence Therapeutics plc - SLN
lincolnjournal.com ·
- Silence Therapeutics Price Target Cut to $20.00/Share From $75.00 by HC Wainwright & Co.
Moomoo ·
- H.C. Wainwright Downgrades Silence Therapeutics(SLN.US) to Hold Rating, Cuts Target Price to $20
Moomoo ·
- Merck KGaA Announces Agreement to Acquire Silence Therapeutics, Expanding Its siRNA Pipeline
Oncodaily ·
Silence Therapeutics plc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $559,000 | $43.3M | $31.6M | $21.7M |
| Net income | -$88.6M | -$45.3M | -$54.2M | -$50.3M |
| Diluted EPS | $-0.63 | $-0.33 | $-0.49 | $-0.52 |
| Total assets (year end) | $131.4M | $202.6M | $119.4M | – |
| Cash and equivalents (year end) | $11.3M | $121.3M | $68.8M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Silence Therapeutics plc
- Ticker
- SLN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- London
- Incorporated in
- United Kingdom
- SEC CIK
- 1479615
Frequently asked questions
What exchange is Silence Therapeutics plc listed on?
Silence Therapeutics plc trades on the Nasdaq under the ticker symbol SLN.
What industry is Silence Therapeutics plc in?
Silence Therapeutics plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Silence Therapeutics plc headquartered?
Silence Therapeutics plc's business address on file with the SEC is in London.
How much revenue did Silence Therapeutics plc report?
Silence Therapeutics plc reported $559,000 in revenue for calendar year 2025, according to its SEC filings.